XSOLLA
Xsolla, a global video game commerce company, announces the opening of its first Canadian office in Montreal in collaboration with GameAddik. This strategic expansion into one of North America's most dynamic tech hubs underscores Xsolla's dedication to innovation and its mission to better serve the burgeoning gaming industry and developers in Quebec and across Canada.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240808870268/en/
(Graphic: Xsolla)
Montreal has long been recognized for its dynamic gaming ecosystem and innovative tech community. By establishing a presence in this thriving city, Xsolla aims to expand its operations with incredible local talent and foster closer relationships with regional developers. The new office will serve as a hub for Xsolla's operations in Canada, enhancing its ability to offer tailored and localized solutions to its current partners and thousands of new game developers and publishers in the region.
"Montreal is renowned for its dynamic gaming ecosystem and innovative tech community. Our presence here will enable us to better support our local and global partners and tap into the incredible local talent pool," said Xsolla's president, David Stelzer. “This new office in Montreal will be crucial in strengthening our relationships with local game developers and facilitating our mission to empower our partners to reach their full potential.”
As part of this expansion, Xsolla plans to hire up to 50 regional employees over the next two years, targeting a mix of roles in business development, customer support, and technical services. This investment will strengthen its capacity to deliver cutting-edge solutions and exceptional service.
This strategic partnership with GameAddik originated from the successful cross-service opportunities explored with its dedicated marketing solution, GameRebellion, creating a robust support system for game developers in Canada.
"We are excited about our collaboration with Xsolla, as our GameRebellion project shares a common vision of empowering studios to achieve greater success," said Alain Carpentier, CTO at GameAddik.
"Our partnership with Xsolla is a game-changer for GameAddik," said Eric Jodoin, CEO of GameAddik. "Teaming up with such a prominent company allows us to better support the industry in striving for success."
The new office will be a one-stop shop for companies looking for industry-leading and cutting-edge solutions to fund, launch, market, monetize, and sell their games to local gamers and fans of their games worldwide. Xsolla provides advanced tools and services to help game developers accelerate their business by reaching players who want to pay for their gaming experiences locally using their preferred payment methods. With the ability to enable transactions in over 130 currencies and 20 languages, Xsolla has already facilitated access to new gamers for game developers worldwide.
For more information about the Xsolla Canadian office, please visit xsolla.pro/montreal.
About Xsolla
Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in Montreal, London, Berlin, Beijing, Guangzhou, Seoul, Tokyo, Kuala Lumpur, Raleigh, and cities around the world, Xsolla supports major gaming titles like Valve, Take-Two, KRAFTON, Nexters, NetEase, Playstudios, Playrix, miHoYo, and more.
For additional information and to learn more, please visit xsolla.com.
About GameAddik
Founded in 2015, GameAddik is an advertising technology company that provides tech-driven marketing solutions for the gaming industry. Trusted by over 200 global brands, GameAddik is a leader in understanding gaming audiences and delivering measurable performance marketing solutions for its clients across its three business segments: PWN Games (performance marketing), Elusive (performance-driven influencer marketing), and GameRebellion (game audience and industry data and analytics).
For more information, please visit gameaddik.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240808870268/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Shield and PwC UK Forge Strategic Collaboration to Deliver Future-Ready Communications Compliance18.9.2025 08:00:00 CEST | Press release
Collaboration brings together Shield's AI-first platform with PwC's surveillance expertise to deliver measurable compliance outcomes Shield, a leading AI platform for digital communication governance and archiving, today announced a collaboration with PwC UK, one of the world’s most trusted professional services firms. The alliance brings together Shield’s unified, cloud-native solution with PwC’s specialist expertise in communications surveillance delivery, regulatory compliance and complex programme execution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917394739/en/ Shield and PwC launch a strategic collaboration to modernize eComms surveillance with AI-driven compliance solutions for financial institutions. The collaboration is designed to support institutions as they modernise their approach to communications monitoring, helping them implement an advanced and proactive risk management approach at scale and with co
Almirall Presents Long‑Term Results from First Real‑World Dermatology Study Using WHO‑5 Well‑Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 202518.9.2025 08:00:00 CEST | Press release
Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults with moderate-to-severe psoriasis over two years.POSITIVE is the first real-world evidence (RWE) study in dermatology to use the WHO-5 Well-Being Index as a primary endpoint, complementing traditional measures of skin disease (PASI, PGA), quality of life (DLQI), with the assessment of psychological well-being, marking a paradigm shift towards holistic management of psoriasis.The POSITIVE study highlights Almirall’s leadership in advancing patient-centred dermatology aligned with the WHO’s health definition and recent resolution on skin diseases.Almirall’s extensive scientific contributions to EADV 2025 include 44 abstracts across key dermatological conditions including atopic dermatitis, psoriasis, actinic keratosis, and hidradenitis suppurativa, and two expert-led symposia. Almirall, S.A. (ALM
Curatis: FDA Minutes Confirm Positive Outcome of Meeting on 9. September 2025 – Corticorelin on Track for Phase 318.9.2025 07:00:00 CEST | Press release
Curatis Holding AG (SIX:CURN) received the official minutes from the FDA meeting which took place on 9. September. Based on the totality of the feedback and discussions, Curatis can proceed as planned with the clinical development of corticorelin. Corticorelin is under development as a novel treatment intended to reduce or even eliminate steroid use and associated toxicities thereby potentially impacting the quality of life of patients suffering from peritumoral brain edema (PTBE) associated with metastatic (secondary) brain tumors. The virtual meeting with the FDA provided the opportunity to discuss the clinical development plan for corticorelin and encompassed CMC (Chemistry, Manufacturing and Control), nonclinical and clinical aspects. The offical FDA minutes which Curatis received after publication of the half year results reflect the positive outcome. Curatis may proceed without delay to a regulatory submission supporting a pivotal study in patients suffering from PTBE secondary t
Galderma Launches Transformative Skincare Segment With Cetaphil’s New Skin Activator Hydrating & Firming Line, in Partnership With Actor and Filmmaker Mariska Hargitay18.9.2025 07:00:00 CEST | Press release
Cetaphil's new Skin Activator Hydrating & Firming Line harnesses a proprietary formula, co-created with dermatologists and offering targeted, high-performance skincare designed to improve the appearance of skin affected by dermatoporosis The line’s new Skin Activator technology uses microdosed alpha hydroxy acid (AHA) and encapsulated centella asiatica (CICA) to wake up sleeping surface skin cells To help bring this segment-defining product line to life, Cetaphil is partnering with acclaimed actress, director, and advocate, Mariska Hargitay, a powerful voice in embracing beauty at every stage Galderma today announced Cetaphil, the dermatologist-recommended brand trusted by millions with sensitive skin, is redefining daily skincare with its new Skin Activator Hydrating & Firming line. The launch marks an entirely new skincare segment of advanced hydration and firming solutions designed specifically for improving the appearance of aging, thinning, and fragile skin. As people age, surface
Merck Opens Climate-Neutral €150 Million Filter Manufacturing Facility in Ireland18.9.2025 07:00:00 CEST | Press release
Part of company’s €440 million investment in Ireland, strengthens Merck’s in-region-for-region supply resilienceMerck’s first climate-neutral manufacturing facility, powered by 100 percent renewable electricityNew Blarney site in Cork, Ireland expands filter manufacturing capacity, creating more than 200 jobs by 2028 Merck, a leading science and technology company, has opened today its €150 million filter manufacturing facility in Blarney Business Park, Cork, Ireland. The site is Merck’s first manufacturing facility designed for full climate-neutral operations, marking a key milestone in the company’s ambition to achieve climate neutrality by 2040. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917767425/en/ Merck's new Blarney site in Cork expands company's filter capacity, creating 200+ jobs by 2028 The 3,000-square-meter cleanroom facility supports global demand for critical filtration products used in the manufacturin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom